Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis.

Circ Cardiovasc Interv

From the Cardiovascular Institute, Hospital Clínico San Carlos and Universidad Complutense, IdISSC, Madrid, Spain (G.T.-C., P.J.-Q., M.d.T., C.M., L.N.-F.); Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Canada (J.R.-C., F.C.-P., M.d.T.); Department of Cardiology, Utrecht Medisch Centrum, the Netherlands (R.R.-O., P.S.); Department of Cardiology, Ferrarotto Hospital, University of Catania, Italy (M.B., D.T., C.T.); Department of Cardiology, Rangueil University Hospital, Toulouse, France (T.L., F.C.-P.); Instituto de Ciencias del Corazón (ICICOR), CIBERCV, Hospital Clínico Universitario de Valladolid, Spain (I.A.-S.); Heart Center Lucerne, Luzerner Kantonsspital, Switzerland (S.T., L.L.); Division of Cardiology, St. Michael's Hospital, Toronto University, Ontario, Canada (A.N.C.); CIBERCV, Hospital Clínico Universitario Virgen de la Victoria, Malaga, Spain (A.J.M.-G., J.M.H.-G.); Department of Cardiology, Hospital General Universitari Vall d'Hebron, Barcelona, Spain (V.S., B.G.d.B.); Department of Cardiology, Città della Salute e della Scienza Hospital, University of Turin, Italy (F.G., F.B.); and Department of Cardiology, Hospital Universitario Marques de Valdecilla, Santander, Spain (G.V., J.M.d.l.T.H.).

Published: March 2018

AI Article Synopsis

  • Chronic liver disease increases the risk of complications and mortality in patients undergoing transcatheter aortic valve replacement (TAVR), yet there is limited data on this population.
  • A study of 114 patients with chronic liver disease showed similar in-hospital mortality and complications compared to a matched group without liver disease, although acute kidney injury was more frequent in the liver disease group.
  • Predictors of mortality included lower glomerular filtration rate and classification of liver disease as Child-Pugh class B or C, with very poor survival rates for patients exhibiting both factors, suggesting cautious use of TAVR in this demographic.

Article Abstract

Background: Chronic liver disease is a known risk factor for perioperative morbidity and mortality in patients undergoing cardiac surgery. Very little data exist about such patients treated with transcatheter aortic valve replacement (TAVR). Our objective was to evaluate early and late clinical outcomes in a large cohort of patients with liver disease undergoing TAVR and to determine predictive factors of mortality among these patients.

Methods And Results: This multicenter study collected data from 114 patients with chronic liver disease who underwent TAVR in 12 institutions. Perioperative and long-term outcomes were compared with a cohort of 1118 patients without liver disease after a propensity score-matching analysis (114 matched pairs). In-hospital mortality and vascular and bleeding complications were similar between matched groups. Acute kidney injury was more common in liver disease group (30.8% versus 13.5%; =0.010). Although cardiovascular mortality was similar between groups (9.4% versus 6.5%; =0.433) at 2-year follow-up, noncardiac mortality was higher in the liver group (26.4% versus 14.8%; =0.034). Lower glomerular filtration rate (hazard ratio, 1.10, for each decrease of 5 mL/min in estimated glomerular filtration rate; 95% confidence interval, 1.03-1.17; =0.005) and Child-Pugh class B or C (hazard ratio, 3.11; 95% confidence interval, 1.47-6.56; =0.003) were the predictors of mortality in patients with chronic liver disease, with a mortality rate of 83.2% at 2-year follow-up in patients with both factors (estimated glomerular filtration rate <60 mL/min and Child-Pugh B or C).

Conclusions: These findings suggested that TAVR is a feasible treatment for severe aortic stenosis in patients with early-stage liver disease or as bridge therapy before a curative treatment of the hepatic condition. Patients with Child-Pugh class B-C, especially in combination with renal impairment, had a very low survival rate, and TAVR should be carefully considered to avoid a futile treatment. These results may contribute to improve the clinical decision-making process and management in patients with liver disease.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005727DOI Listing

Publication Analysis

Top Keywords

liver disease
28
patients liver
12
chronic liver
12
glomerular filtration
12
filtration rate
12
clinical outcomes
8
patients
8
liver
8
disease undergoing
8
transcatheter aortic
8

Similar Publications

Rheumatoid arthritis is an autoimmune disorder affecting multiple joints and requires lifelong treatment. Present study was designed to formulate Esculin-loaded chitosan nanoparticles (ENPs) and evaluation of its anti-inflammatory and anti-arthritic action. The acute toxicity study of ENPs was also performed.

View Article and Find Full Text PDF

Viral infections in celiac disease: what should be considered for better management.

Clin Exp Med

December 2024

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Following a gluten-free diet (GFD) is known as the main effective therapy available for celiac disease (CD) patients, which in some cases is not enough to heal all patients presentations completely. Accordingly, emerging researchers have focused on finding novel therapeutic/preventive strategies for this disorder. Moreover, previous studies have shown that celiac patients, especially untreated subjects, are at increased risk of developing viral and bacterial infections, which can become a challenge for the clinician.

View Article and Find Full Text PDF

Riders on the Storm.

Transpl Infect Dis

December 2024

Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

This case involves a 52-year-old male, who underwent a deceased donor orthotopic liver transplant 7 months prior, presented with a 2-week history of persistent fever, anemia, thrombocytopenia, and mild elevation of liver enzymes. Upon hospital admission, the patient was febbrile, alert and oriented, hemodynamically stable. Laboratory exams revealed worsening leukopenia, anemia, thrombocytopenia, hyponatremia, and elevated ferritin.

View Article and Find Full Text PDF

Introduction: The appropriate duration of therapy for uncomplicated gram-negative bloodstream infection (GN-BSI) in liver transplant (LTx) recipients remains unknown. This study aims to explore the effectiveness of a short-course antimicrobial therapy.

Methods: This retrospective study was performed in a single LTx center in Japan.

View Article and Find Full Text PDF

Background: Postoperative acute kidney injury (AKI) and chronic kidney disease (CKD) following pediatric liver transplantation (PLT) have not been comprehensively studied. This study aimed to evaluate the correlation between AKI and both 1-year CKD and mortality.

Methods: This retrospective study included 132 children aged between 3 months and 12 years who underwent PLT between 2017 and 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!